Wednesday, February 8, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Research
1 of 2
Previous |
Next
Research
Tooling Up for Clinical Trials
Clinical trials represent an expensive and time-consuming barrier for pharma firms. Can the proliferation of IT tools keep clinical trials manageable in the face of growing regulatory demands? Neil Davey investigates…
No Comments
Talking with JSS Medical’s Dr John Sampalis
Dr John Sampalis, President and founder of JSS Medical Research Inc.
No Comments
Maximizing randomizations through referral response
Lost-to-follow-up is one of the greatest correctable barriers to completing clinical study patient enrollment
No Comments
How to Juggle Clinical Development
With pharma companies coming under increasing pressure to improve profits and speed product development times, how can the industry harness technology to drive down the cost of the clinical development process? Ed Seguine, CEO of Fast Track Systems, Inc., explains.
No Comments
1 of 2
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.